• Genpact recently declared a third-quarter 2026 cash dividend of US$0.1875 per share and earlier partnered with Nestlé Business Solutions to build a new Global Capability Center in Hyderabad, India, focused on AI-driven process transformation.
• Genpact was also named the sole Rising Star in ISG’s 2026 Databricks Ecosystem Partners report, underscoring its growing role in AI-ready data and agentic AI solutions for large enterprises.
• We’ll now examine how Genpact’s ISG Rising Star recognition in the Databricks ecosystem could influence its AI-focused investment narrative.

Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 29 best rare earth metal stocks of the very few that mine this essential strategic resource.

Genpact Investment Narrative Recap

To own Genpact, you need to believe it can shift from slower growing legacy BPO into higher value, AI centered solutions while managing a muted demand backdrop and rising competition. The latest dividend announcement does not materially change that near term story, while the biggest risk remains whether its heavy AI reinvestment and push into annuitized, large contracts can offset pressure in Core Business Services and deliver on current revenue and earnings expectations.

The ISG Rising Star recognition in the Databricks Ecosystem Partners report looks most relevant here, because it directly reinforces Genpact’s AI and data centric positioning at the heart of its growth thesis. Being the only Rising Star highlights third party validation of its AI ready data and agentic AI capabilities, which ties closely to the key catalyst of scaling Advanced Technology Solutions as a higher margin, more productive part of the portfolio.

Yet investors should also be aware that if Genpact’s AI investments fail to scale as envisioned, its ability to balance reinvestment with shareholder returns could...

Genpact’s narrative projects $6.4 billion revenue and $745.1 million earnings by 2029. This requires 7.4% yearly revenue growth and about a $175.5 million earnings increase from $569.6 million today.

Uncover how Genpact's forecasts yield a $42.45 fair value, a 39% upside to its current price.

Exploring Other Perspectives

Before this news, the most optimistic analysts were assuming Genpact could reach about US$6.6 billion in revenue and roughly US$800 million in earnings by 2029, which is a much more upbeat story than the baseline view and one that could shift meaningfully as the ISG Rising Star recognition and broader AI momentum are reassessed.

Explore 5 other fair value estimates on Genpact - why the stock might be worth over 3x more than the current price!

The Verdict Is Yours

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Genpact research is our analysis highlighting 4 key rewards that could impact your investment decision.
• Our free Genpact research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Genpact's overall financial health at a glance.

Interested In Other Possibilities?

Our top stock finds are flying under the radar-for now. Get in early:

• Explore 26 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
• Find 45 companies with promising cash flow potential yet trading below their fair value.
• Capitalize on the AI infrastructure supercycle with our selection of the 54 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.